| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 05/11/2005 | CN1200747C Low dose estrogen interupted hormone replacement therapy |
| 05/11/2005 | CN1200729C Vaginal-applied interferon table and its preparing process |
| 05/11/2005 | CN1200727C Pharmaceutical compositions based on alpha-cyclodextrin for oral administratio nof LH-RH analogues |
| 05/11/2005 | CN1200726C Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 05/11/2005 | CN1200714C Use of diterpenoid triepoxides as anti-proliferative agent |
| 05/10/2005 | US6890945 Administering a imidazo(4,5,1-ij)quinoline compound |
| 05/10/2005 | US6890922 For treatment of erectile dysfunction as well as female sexual dysfunction, incontinence, and hypertrophy of the prostate; inhibitors of cGMP-metabolizing phosphodiesterases (cGMP= cyclic guanosine monophosphate) |
| 05/06/2005 | WO2005023812A3 Piperazines as oxytocin agonists |
| 05/06/2005 | WO2005009436A8 Dispersible formulation of an anti-inflammatory agent |
| 05/05/2005 | US20050096479 Novel succinate salt of O-desmethyl-venlafaxine |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096388 Compositions and methods for treating or preventing diseases of body passageways |
| 05/05/2005 | US20050096359 melanocortin receptor agonist, antagonist; preventing or treating inflammatory diseases, AIDS, obesity, bulimia, anorexia or sexual dysfunction; N-(2-aminoethyl)-3'-[1-{N-(1-benzylpiperidin-4-yl)-N-(2-naphthylacetyl)aminoethyl][1,1'-biphenyl)-2-carboxamide dihydrochloride |
| 05/05/2005 | US20050096356 2-[[6-Methoxy-3-pyridinyl]methyl]amino-N-[3-(trifluoromethyl)phenyl]benzamide hydrochloride salt or its tautomer; treating retinopathy or age-related macula degeneration |
| 05/05/2005 | US20050096326 4-(4-methylpiperazin-1-yl)4V-(4-morpholinophenyl)-indan-2-carboxamide; h5-HT1B receptor antagonist; serotonin-mediated disorders; oral bioavailability |
| 05/05/2005 | US20050096320 potent inhibitors of cyclic guanosine 3',5'-monophosphate-metabolizing phosphodiesterases (cGMP-PDEs)/phosphodiesterase isoenzymes PDE-I, PDE-II, PDE-V; therapeutic, antiaggregatory, antithrombotic, antiproliferative, antivasospastic, vasodilatory, natriuretic and diuretic effects; erectile dysfunction |
| 05/05/2005 | US20050096313 Substance P; 2-(phenyl)-4-(3-oxo-piperazin-1-yl-)-piperidine-1-carboxylic acid; benzyl-methylamide; antagonists of the NK1 receptor; antidepressant, antiolytic; antiemetic |
| 05/05/2005 | US20050096312 Antiserotonine agents; antidepressants; eating disorders; anxiolytic agents; sleep disorders; gastrointestinal disorders; cardiovascular disorders; muscular disorders; endocrine system diseases; muscular disorders; psychological disorders |
| 05/05/2005 | US20050096279 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 05/05/2005 | US20050096268 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 05/05/2005 | US20050095238 Treating a disease associated with leukocyte infiltration of mucosal tissues, such as inflammatory bowel disease, asthma, graft vs host disease, pancreatitis, diabetes, or sinutitis with a humanized immunoglobulin or antigen-binding fragment thereof having binding specificity for alpha 4 beta 7 integrin |
| 05/05/2005 | US20050095232 Vaginal care composition |
| 05/04/2005 | EP1528058A1 Polymorphic crystalline forms of celecoxib |
| 05/04/2005 | EP1527076A1 Dihydro-dibenzo (b,e) oxepine based selective estrogen receptor modulators, compositions and methods |
| 05/04/2005 | EP1527075A1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 05/04/2005 | EP1527068A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 05/04/2005 | EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 05/04/2005 | EP1526895A2 Methods for treating carbonic anhydrase mediated disorders |
| 05/04/2005 | EP1526869A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 05/04/2005 | EP1526847A2 Pharmaceutical dosage form comprising a sulfite compound |
| 05/04/2005 | EP1526846A2 Gelatin capsule exhibiting reduced cross-linking |
| 05/04/2005 | EP1526845A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 05/04/2005 | EP1526844A2 Pellicle-resistant gelatin capsule |
| 05/04/2005 | EP1411881B1 5ht2c receptor modulators |
| 05/04/2005 | EP1307471B1 16alpha-methyl or ethyl substituted estrogens |
| 05/04/2005 | EP1218395B1 Antisense modulation of x-linked inhibitor of apoptosis expression |
| 05/04/2005 | EP1124810B1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/04/2005 | EP1119567B1 Quinazoline derivatives |
| 05/04/2005 | CN2696635Y Vagina suppository and settling device for controlling estrous cycle of ewe |
| 05/04/2005 | CN1612893A VEGF peptides and their use for inhibiting angiogenesis |
| 05/04/2005 | CN1612869A Novel 1, 2, 4-thiadiazolium derivatives as melanocortin receptor modulators |
| 05/04/2005 | CN1612864A Novel alkansulfonamides as endothelin antagonists |
| 05/04/2005 | CN1612745A Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 05/04/2005 | CN1612741A Use of sulfated glycosaminoglycans for establishing effective labor in women |
| 05/04/2005 | CN1611252A Medicinal protective pad |
| 05/04/2005 | CN1611251A Medicinal sanitary protective pad |
| 05/04/2005 | CN1611250A Medicinal protective pad |
| 05/04/2005 | CN1611231A Chinese medicinal composition for treating endometriosis menstrual ab dominal pain and its preparing method |
| 05/04/2005 | CN1611230A Chinese medicinal composition for treating postartum and abortive complication and its preparing method |
| 05/04/2005 | CN1611222A Composition for contraception |
| 05/04/2005 | CN1611215A Pharmaceutical use of dihydro myricetin |
| 05/04/2005 | CN1200103C Fowl castration recombinant gene vector |
| 05/04/2005 | CN1199950C Quinolene derivatives as anti-inflammation agents |
| 05/04/2005 | CN1199688C Growth hormone for ovarian functional cell and its prepn |
| 05/04/2005 | CN1199687C Method for extracting gonad stimulating hormone from pregnant mare blood |
| 05/04/2005 | CN1199674C Douching lotion for treating women's genital system disease |
| 05/04/2005 | CN1199669C Medicine for curing cervicitis and preparing method thereof |
| 05/04/2005 | CN1199647C Application of icariin in preparation of medicine for preventing and treating sexual disfunction |
| 05/04/2005 | CN1199645C Application of N-acetyl-D-aminoglucose in the preparation of medicine for treating urogenital system infection |
| 05/04/2005 | CN1199621C Device and medicine for treatment of dysmenorrhea |
| 05/03/2005 | US6888043 Feminine care products for the delivery of therapeutic substances |
| 05/03/2005 | US6888004 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 05/03/2005 | US6887987 DNA encoding the human serine protease T |
| 05/03/2005 | US6887981 Natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 05/03/2005 | US6887905 Treatment of depression or generalized anxiety disorder |
| 05/03/2005 | US6887891 Derivatives of lipoic acid, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 05/03/2005 | US6887886 Therapeutic compositions comprising excess enantiomer |
| 05/03/2005 | US6887874 For producing an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal; therapy of cancer, rheumatoid arthritis |
| 05/03/2005 | US6887844 To stimulate the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM) |
| 05/03/2005 | CA2486473A1 Vaginal care composition |
| 05/03/2005 | CA2347950C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 04/28/2005 | WO2005037288A1 A pharmaceutical product for hormone replacement therapy comprising tibolone or a derivative thereof and estradiol or a derivative thereof |
| 04/28/2005 | WO2005036989A1 Health food containing hyaluronic acid and dermatan sulfate |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | WO2004014842A8 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/28/2005 | WO2003099201A3 Compositions and methods of use for a fibroblast growth factor |
| 04/28/2005 | WO2003072067A3 Compositions and methods for treating epithelial and retinal tissue diseases |
| 04/28/2005 | US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 04/28/2005 | US20050090536 Substituted pyrrol-3-ylisoxazoles, e.g., N-benzyl-4-[4-(o-chlorophenyl)-5-isoxazolyl)pyrrole-2-carboxamide; treating diseases that are alleviated by a protein kinase inhibitor, particularly cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 04/28/2005 | US20050090517 Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 04/28/2005 | US20050090503 5-HT receptor ligands and uses thereof |
| 04/28/2005 | US20050090491 2'-Methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/28/2005 | US20050090475 administering a combination of estrogen and a progestin for 42 consecutive days followed by a hormone-free period of from 4 to 8 days, where the estrogen dosage remains constant over each 21 day cycle and the progestin dosage increases in three phases over each day cycle |
| 04/28/2005 | US20050090474 Methods and compositions for enhancing and inhibiting fertilization |
| 04/28/2005 | US20050090000 Novel human 7TM protein and polynucleotides encoding the same |
| 04/28/2005 | US20050089911 87 human secreted proteins |
| 04/28/2005 | US20050089535 Delivery of biologically active agents |
| 04/28/2005 | US20050089518 Prospective identification and characterization of breast cancer stem cells |
| 04/28/2005 | US20050089495 Transdermal transport of compounds |
| 04/28/2005 | US20050089479 Delivery of sedative-hypnotics through an inhalation route |
| 04/28/2005 | US20050087198 Method for systemic drug delivery through the nail |
| 04/28/2005 | CA2543447A1 Antibody and use of the same |
| 04/28/2005 | CA2542504A1 Lipids containing omega-3 and omega-6 fatty acids |
| 04/28/2005 | CA2540191A1 1- 2' (1, 4'-biperidin-1'-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
| 04/27/2005 | EP1526134A2 Triazolyl tropane derivatives as ccr5 modulators |
| 04/27/2005 | EP1525883A1 Ciclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/27/2005 | EP1525215A1 Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy |
| 04/27/2005 | EP1524997A1 Stable liquid parenteral parecoxib formulation |
| 04/27/2005 | EP1524983A1 COMPOSITION CONTAINING AN ANDROGENOUS 11&bgr;-HALOGEN STEROID AND A PROGESTATIONAL HORMONE, AND MALE CONTRACEPTIVE BASED ON SAID COMPOSITION |
| 04/27/2005 | EP1524976A1 A non-hormonal approach to male contraception |